Investigational Site Number 8402051 — La Mirada, California

Investigational Site Number 8402051 is a clinical research site located in La Mirada, California, United States 90638.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 8402051 has participated in 1 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus.

Sponsors: Lexicon Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in La Mirada

Browse all research sites in California · View every site in La Mirada

• Biola University
• Synergy Research Site
• Research Site
• Medvin Clinical Research, 15627 Imperial Highway,
• Ardelyx Investigative Site 284
• Furiex Research Site
• BLI Research Site 30
• Novo Nordisk Investigational Site
• Braintree Research Site 32
• McGuire, Jr. La Mirada, CA /ID# 116257
• Medvin Clinical Research

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 8402051?

Investigational Site Number 8402051 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 8402051 conducted?

Investigational Site Number 8402051 has 1 clinical trials on record. Their work covers Type 2 Diabetes Mellitus.

Is Investigational Site Number 8402051 accredited by Crixeo Clinical Trials?

Investigational Site Number 8402051 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 8402051?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.